Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alterity, Ammax, Axalbion, Bridge, Compass, Enzychem, Jupiter, Menarini, Neotx, Numinus, Obseva, Prilenia, Radius, Rocket, Senhwa, Synairgen, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Atea, Avadel, Avrobio, Cour, Dicerna, Edesa, Eli Lilly, Entasis, Galera, Harbour, Immune, Immunitybio, Inhibikase, Iterion, Noxxon, Ono, Opthea, Paratek, Pharnext, Seal Rock, Sifi, Small, Statera, Ultragenyx, Vyne.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alphamab, Applied Therapeutics, Avelas, Biogen, Biomx, Bioxcel, Blade, Cardiol, Homology, Logicbio, Mesoblast, Moleculin, Nervgen, Oryzon, Phathom, Radius, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Astrazeneca, Eli Lilly, Medigen, Merck, Protalix, RDIF, TG.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Alimera, Anavex, Apnimed, Atara, Biogen, BMS, Brainstorm, Crispr, EMD, Eyepoint, Faraday, First Wave, Genentech, Horizon, I-Mab, Immune-Onc, Immunitybio, Neoimmunetech, Neurobo, Oncolytics, Oryzon, Outlook, Resverlogix, Rhizen, Sanofi, Smart Immune, TC, Tizona, Ultimovacs, Union, VBI, Veru, Vistagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaccine, Aerie, Agenus, Apeiron, Arcturus, Ascletis, Astellas, BMS, Inflarx, Inhibrx, Inovio, Istari, Otonomy, Vtv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Aligos, Astrazeneca, Bicycle, Diurnal, Idorsia, Galmed, Oxurion, Regenxbio, Reistone, Repertoire, Sarepta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Argenx, Cyprium, Fortress, Nanoscope, Nkarta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Brickell, Bristol Myers, Celltrion, Denali, G1, Genetx, Inhalon, Jounce, Minervax, Timber, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Apexigen, Cassava, Covicept, Dialectic, Elicio, Entera, Legacy, Panther, Pharmather, Precirix, Takeda, Vaxart.